Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||1.90%||8.03||0.7%||$561.33m|
|GILD||Gilead Sciences, Inc.||0.72%||65.77||1.0%||$463.29m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.80%||494.64||2.7%||$449.68m|
|VRTX||Vertex Pharmaceuticals, Inc.||1.83%||221.10||1.9%||$383.88m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.45%||157.54||2.0%||$298.86m|
|EXAS||EXACT Sciences Corp.||2.66%||130.52||18.4%||$192.20m|
|NBIX||Neurocrine Biosciences, Inc.||-0.05%||95.00||4.9%||$177.73m|
|CRSP||CRISPR Therapeutics AG||0.60%||123.85||0.6%||$174.50m|
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. It operates through Sorrento Therapeutics and Scilex segments. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.